New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network.
Campania Oncology Network
cancer care
cancer delay
continuity of care
multidisciplinary oncologic groups
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
12
09
2022
received:
08
03
2022
accepted:
27
09
2022
medline:
13
4
2023
entrez:
11
4
2023
pubmed:
12
4
2023
Statut:
ppublish
Résumé
The primary goal of the Campania Oncology Network (ROC) was to reduce cancer delay and care fragmentation through the establishment of cancer-specific multidisciplinary oncologic groups (GOMs) and diagnostic and therapeutic assistance paths (PDTAs). Five cancer centres of the ROC, with their own cancer specific GOM, were selected. In our analysis, we have focused on four neoplasms: lung, colon, ovarian and prostate cancers. The median time for pre-GOM and GOM Times was calculated for each tumour site. Univariate and multivariate logistic regressions were performed to individuate risk factors for pre-GOM and GOM Time. Significant differences were observed for prostate cancer compared to other patients either for pre-GOM or GOM Times. Significant risks were found for ovarian and prostate cancers in pre-GOM time and for prostate cancer in GOM-Time. This experience will produce knowledge and data to guide decision-making and to manage more effectively the challenges of fighting cancer in Campania region. The Valutazione Percorso Rete Oncologica Campana (ValPeROC) study evaluates, for the first time, the ROC activity, through the analysis of key performance indices. Pre-GOM and GOM Time represent the quality of the entire regional health system and are useful to define models, which can evaluate the performance of the ROC over time.
Types de publication
Journal Article
Langues
eng
Pagination
e13736Subventions
Organisme : 5x1000 project titled "Valutazione percorso rete oncologica campana ValPeROC", Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy
ID : M5/7
Organisme : Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Organisme : BMS Bristol Meyer Squibb
Organisme : Astrazeneca
Investigateurs
Antonio Aquino
(A)
Claudia Bonito
(C)
Carlo Buonerba
(C)
Fabrizio Caccavallo
(F)
Chiara Carlomagno
(C)
Marisa Cavaliere
(M)
Sara Centonze
(S)
Simona Damiano
(S)
Chiara De Divitiis
(C)
Rosa De Nardo
(R)
Antonio Del Deo Vito
(A)
Davide D'Errico
(D)
Giorgio Esposito
(G)
Lucia Esposito
(L)
Vincenzo Famiglietti
(V)
Lucia Formisano
(L)
Luigi Formisano
(L)
Elisena Franzese
(E)
Valeria Gaeta
(V)
Elisabetta Gragnano
(E)
Rosaria Grimaldi
(R)
Gelsomina Iovane
(G)
Rossella Lauria
(R)
Giovanna Migliore
(G)
Maria Mirto
(M)
Angelina Napoletano
(A)
Domenico Napoli
(D)
Pasquale Vitale
(P)
Stefano Pepe
(S)
Maria Pia Rambaldo
(MP)
Massa Renato
(M)
Marilena Rescigno
(M)
Emanuela Rossi
(E)
Giuseppe Santabarbara
(G)
Concetta Stanzione
(C)
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Camilloni, L., Ferroni, E., Cendales, B. J., Pezzarossi, A., Furnari, G., Borgia, P., Guasticchi, G., Rossi, P. G., & the Methods to increase participation Working Group. (2013). Methods to increase participation in organised screening programs: A systematic review. BMC Public Health, 13, 464. https://doi.org/10.1186/1471-2458-13-464
Crispo, A., Montella, M., Barba, M., Schittulli, F., de Marco, M. R., Grimaldi, M., Quaranta, M., Serravezza, G., Savastano, C., Botti, G., la Vecchia, C., & D'Aiuto, G. (2009). Association between mode of breast cancer detection and diagnosis delay. Breast, 18, 382–386. https://doi.org/10.1016/j.breast.2009.10.001
De Placido, S., Bracale, U., Pacelli, R., Sodo, M., Merola, G., Silvestri, V., & Corcione, F. (2020). A new strategy for a high tumour burden region: The Campania oncological network. Translational Medicine @ UniSa, 21, 59–60.
Di Napoli, A., & Franco, F. (2020). Determinazione della numerosità campionaria. Giornale Di Clinica Nefrologica E Dialisi, 32, 26–29. https://doi.org/10.33393/gcnd.2020.1102
Espinel‐Flores, V., Vargas, I., Eguiguren, P., Mogollón‐Pérez, A. S., Ferreira de Medeiros Mendes, M., López‐Vázquez, J., Bertolotto, F., & Vázquez, M. L. (2022). Assessing the impact of clinical coordination interventions on the continuity of care for patients with chronic conditions: Participatory action research in five Latin American countries. Health Policy and Planning, 37(1), 1–11. https://doi.org/10.1093/heapol/czab130
Gildea, T. R., DaCosta Byfield, S., Hogarth, D. K., Wilson, D. S., & Quinn, C. C. (2017). A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. ClinicoEconomics and Outcomes Research, 9, 261–269. https://doi.org/10.2147/CEOR.S132259
Gorin, S. S., Haggstrom, D., Han, P. K. J., Fairfield, K. M., Krebs, P., & Clauser, S. B. (2017). Cancer care coordination: A systematic review and meta‐analysis of over 30 years of empirical studies. Annals of Behavioral Medicine, 51(4), 532–546. https://doi.org/10.1007/s12160-017-9876-2
Guarneri, V., Bassan, F., Zagonel, V., Milella, M., Zaninelli, M., Cattelan, A. M., Vianello, A., Gori, S., Aprile, G., Azzarello, G., Chiari, R., Favaretto, A., Oliani, C., Scola, A., Pastorelli, D., Mandarà, M., Zustovich, F., Bernardi, D., Chiarion‐Sileni, V., … Veneto Oncology Network. (2021). Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study. European Journal of Cancer, 147, 120–127. https://doi.org/10.1016/j.ejca.2021.01.021
Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey‐Jones, E., O'Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020). Mortality due to cancer treatment delay: Systematic review and meta‐analysis. BMJ, 371, m4087. https://doi.org/10.1136/bmj.m4087
Hester, C. A., Karbhari, N., Rich, N. E., Augustine, M., Mansour, J. C., Polanco, P. M., Porembka, M. R., Wang, S. C., Zeh, H. J. III, Singal, A. G., & Yopp, A. C. (2019). Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma. Cancer, 125, 3428–3436. https://doi.org/10.1002/cncr.32336
Linee guida AIOM 2021. (2021). Retrieved September 5, 2022, from https://www.aiom.it/en/linee-guida-aiom/
Osservatorio Nazionale di Screening: rapporto sul 2019. (2019). Retrieved February 28, 2022, from https://www.osservatorionazionalescreening.it/content/rapporto-2019
1° annualità Val.Pe.ROC – Rapporto di ricerca. (2021). Retrieved February 28, 2022, from https://www.reteoncologicacampana.it/?page_id=25275
Progetto “Val.Pe.ROC” I Annualità ‐ II Semestre. (2021). Retrieved February 28, 2022, from https://www.reteoncologicacampana.it/?page_id=25294
Kabwe, M., Robinson, A., Shethia, Y., Parker, C., Blum, R., Solo, I., & Leach, M. (2021). Timeliness of cancer care in a regional Victorian health service: A comparison of high‐volume (lung) and low‐volume (oesophagogastric) tumour streams. Cancer Reports (Hoboken), 4(1), e1301. https://doi.org/10.1002/cnr2.1301
Li, X., Scarfe, A., King, K., Fenton, D., Butts, C., & Winget, M. (2013). Timeliness of cancer care from diagnosis to treatment: A comparison between patients with breast, colon, rectal or lung cancer. International Journal for Quality in Health Care, 25(2), 197–204. https://doi.org/10.1093/intqhc/mzt003
Loizzo, M., Cuccurullo, O., & Gallo, F. (2017). The application of the diagnostic therapeutic care pathway for the geriatric patient with anemia at the hospital of Cosenza, Italy: A management tool or a quality project? Annali di Igiene, 29(2), 141–150. https://doi.org/10.7416/ai.2017.2141
Neal, R. D., Tharmanathan, P., France, B., Din, N. U., Cotton, S., Fallon‐Ferguson, J., Hamilton, W., Hendry, A., Hendry, M., Lewis, R., Macleod, U., Mitchell, E. D., Pickett, M., Rai, T., Shaw, K., Stuart, N., Tørring, M. L., Wilkinson, C., Williams, B., … Emery, J. (2015). Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer, 112(1), S92–S107. https://doi.org/10.1038/bjc.2015.48
Onesti, C. E., Tagliamento, M., Curigliano, G., Harbeck, N., Bartsch, R., Wildiers, H., Tjan‐Heijnen, V., Martin, M., Rottey, S., Generali, D., Campone, M., Cristofanilli, M., Pusztai, L., Peeters, M., Berchem, G., Cortes, J., Ruhstaller, T., Ciruelos, E., Rugo, H. S., & Jerusalem, G. (2021). Expected medium‐ and long‐term impact of the COVID‐19 outbreak in oncology. Journal of Global Oncology, 7, 162–172. https://doi.org/10.1200/GO.20.00589
Paterson, C., Bacon, R., Dwyer, R., Morrison, K. S., Toohey, K., O'Dea, A., Slade, J., Mortazavi, R., Roberts, C., Pranavan, G., Cooney, C., Nahon, I., & Hayes, S. C. (2020). The role of telehealth during the COVID‐19 pandemic across the interdisciplinary cancer team: Implications for practice. Seminars in Oncology Nursing, 36(6), 151090. https://doi.org/10.1016/j.soncn.2020.151090
Petrelli, A., Giorgi Rossi, P., Francovich, L., Giordani, B., di Napoli, A., Zappa, M., Mirisola, C., & Gargiulo, L. (2018). Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: Results from the National Health Interview Survey. BMJ Open, 8(9), e021653. https://doi.org/10.1136/bmjopen-2018-021653
Richards, M., Anderson, M., Carter, P., Ebert, B. L., & Mossialos, E. (2020). The impact of the COVID‐19 pandemic on cancer care. Nature Cancer, 1(6), 565–567. https://doi.org/10.1038/s43018-020-0074-y
Rova, A., Tettamanti, A., Pinto, L., & Urbinati, D. (2019). Assessment of the oncological offer among Italian regions: A patient‐centered analysis. Value in Health, 22, S499. https://doi.org/10.1016/j.jval.2019.09.521
Rutter, C. M., Kim, J. J., Meester, R. G. S., Sprague, B. L., Burger, E. A., Zauber, A. G., Ergun, M. A., Campos, N. G., Doubeni, C. A., Trentham‐Dietz, A., Sy, S., Alagoz, O., Stout, N., Lansdorp‐Vogelaar, I., Corley, D. A., & Tosteson, A. N. A. (2018). Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: A modeling study. Cancer Epidemiology, Biomarkers & Prevention, 27(2), 158–164. https://doi.org/10.1158/1055-9965.EPI-17-0378